News coverage about Markel (NYSE:MKL) has trended somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Markel earned a coverage optimism score of 0.21 on Accern’s scale. Accern also gave media coverage about the insurance provider an impact score of 45.7214825727635 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Markel (NYSE:MKL) traded up $15.08 during trading hours on Friday, hitting $1,122.00. 74,950 shares of the company’s stock traded hands, compared to its average volume of 44,369. The firm has a market capitalization of $15,450.00, a P/E ratio of 249.89 and a beta of 1.04. The company has a current ratio of 0.55, a quick ratio of 0.55 and a debt-to-equity ratio of 0.28. Markel has a fifty-two week low of $612.00 and a fifty-two week high of $1,157.30.
Markel (NYSE:MKL) last released its quarterly earnings data on Wednesday, October 25th. The insurance provider reported ($18.82) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($18.03) by ($0.79). Markel had a return on equity of 0.83% and a net margin of 1.60%. research analysts expect that Markel will post 5.56 earnings per share for the current fiscal year.
In other news, insider Alan I. Kirshner sold 100 shares of Markel stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $1,133.50, for a total transaction of $113,350.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Lemuel E. Lewis acquired 1,000 shares of the firm’s stock in a transaction dated Wednesday, November 8th. The shares were purchased at an average cost of $1,080.96 per share, with a total value of $1,080,960.00. Following the completion of the transaction, the director now owns 5,294 shares in the company, valued at approximately $5,722,602.24. The disclosure for this purchase can be found here. Over the last ninety days, insiders have sold 2,307 shares of company stock valued at $2,535,956. Corporate insiders own 2.53% of the company’s stock.
Markel Company Profile
Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.
Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.